Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing Revision: v3.6.0. This change indicates a page revision update without altering the content shown to users.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Study Details page now indicates that it is no longer recruiting participants. It also adds new sections for user guidance (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label, with the revision tag updated to v3.6.0.SummaryDifference0.3%

- Check23 days agoChange DetectedRevision updated to v3.5.5, indicating a patch-level update to the page. There are no substantive content changes associated with this revision.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, marking a new build of the page. This appears to be a version update rather than a content modification.SummaryDifference0.0%

- Check66 days agoChange DetectedA newer ClinicalTrials.gov page revision is now shown compared with the previous revision label.SummaryDifference0.0%

- Check102 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to the trial details content or layout were observed, indicating an internal update.SummaryDifference0.0%

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.